Rocket Pharmaceuticals Stock Investor Sentiment
| RCKT Stock | USD 8.49 0.17 2.04% |
Slightly above 65% of all Rocket Pharmaceuticals' private investors are looking to take a long position. The analysis of the overall investor sentiment regarding Rocket Pharmaceuticals suggests that some traders are interested. Rocket Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Rocket Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Comfort Level 65
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Rocket Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Rocket Pharmaceuticals.
News SentimentBullish | Hype SentimentNeutral | Insider SentimentDisposing |
Rocket Historical Sentiment
Although Rocket Pharmaceuticals' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Rocket, such as negative comments on social media and news outlets, may cause fear in the market and push Rocket Pharmaceuticals' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Rocket.
Rocket |
Rocket Pharmaceuticals Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Rocket Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Rocket Pharmaceuticals that are available to investors today. That information is available publicly through Rocket media outlets and privately through word of mouth or via Rocket internal channels. However, regardless of the origin, that massive amount of Rocket data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Rocket Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Rocket Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Rocket Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Rocket Pharmaceuticals alpha.
Rocket Pharmaceuticals Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 57273 shares by Jonathan Schwartz of Rocket Pharmaceuticals at 30.01 subject to Rule 16b-3 | 12/20/2024 |
2 | Disposition of 896 shares by Militello John of Rocket Pharmaceuticals at 10.38 subject to Rule 16b-3 | 01/23/2025 |
3 | Acquisition by Pratumsuwan Piratip of 22443 shares of Rocket Pharmaceuticals at 10.56 subject to Rule 16b-3 | 02/03/2025 |
4 | Wellington Management Group LLP Increases Stake in Rocket Pharmaceuticals Inc | 02/10/2025 |
5 | Acquisition by Militello John of 29920 shares of Rocket Pharmaceuticals at 9.88 subject to Rule 16b-3 | 02/11/2025 |
6 | KBRA Assigns Preliminary Ratings to RCKT Mortgage Trust 2025-CES2 | 02/12/2025 |
7 | Acquisition by Militello John of 20080 shares of Rocket Pharmaceuticals subject to Rule 16b-3 | 02/13/2025 |
8 | Disposition of 16303 shares by Shah Gaurav of Rocket Pharmaceuticals at 10.58 subject to Rule 16b-3 | 02/21/2025 |
9 | Disposition of 6532 shares by Jonathan Schwartz of Rocket Pharmaceuticals at 10.58 subject to Rule 16b-3 | 02/25/2025 |
10 | Selling Rocket Pharmaceuticals Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders | 02/26/2025 |
11 | Rocket Pharmaceuticals Rings the Nasdaq Stock Market Opening Bell - Nasdaq | 02/28/2025 |
12 | Rocket Pharmaceuticals Announces Earnings Results | 03/04/2025 |
13 | Equities Analysts Offer Predictions for RCKT FY2029 Earnings | 03/05/2025 |
14 | Dana Investment Advisors Inc. Has 221,000 Holdings in Rocket Pharmaceuticals, Inc. | 03/10/2025 |
15 | Acquisition by Shah Gaurav of 81655 shares of Rocket Pharmaceuticals subject to Rule 16b-3 | 03/13/2025 |
16 | Rocket Pharmaceuticals, Inc. Holdings Boosted by Privium Fund Management B.V. | 03/19/2025 |
Additional Tools for Rocket Stock Analysis
When running Rocket Pharmaceuticals' price analysis, check to measure Rocket Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rocket Pharmaceuticals is operating at the current time. Most of Rocket Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rocket Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rocket Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rocket Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.